Common Human Cancer Genes Discovered by Integrated Gene-Expression Analysis

Background Microarray technology enables a standardized, objective assessment of oncological diagnosis and prognosis. However, such studies are typically specific to certain cancer types, and the results have limited use due to inadequate validation in large patient cohorts. Discovery of genes commonly regulated in cancer may have an important implication in understanding the common molecular mechanism of cancer. Methods and Findings We described an integrated gene-expression analysis of 2,186 samples from 39 studies to identify and validate a cancer type-independent gene signature that can identify cancer patients for a wide variety of human malignancies. The commonness of gene expression in 20 types of common cancer was assessed in 20 training datasets. The discriminative power of a signature defined by these common cancer genes was evaluated in the other 19 independent datasets including novel cancer types. QRT-PCR and tissue microarray were used to validate commonly regulated genes in multiple cancer types. We identified 187 genes dysregulated in nearly all cancerous tissue samples. The 187-gene signature can robustly predict cancer versus normal status for a wide variety of human malignancies with an overall accuracy of 92.6%. We further refined our signature to 28 genes confirmed by QRT-PCR. The refined signature still achieved 80% accuracy of classifying samples from mixed cancer types. This signature performs well in the prediction of novel cancer types that were not represented in training datasets. We also identified three biological pathways including glycolysis, cell cycle checkpoint II and plk3 pathways in which most genes are systematically up-regulated in many types of cancer. Conclusions The identified signature has captured essential transcriptional features of neoplastic transformation and progression in general. These findings will help to elucidate the common molecular mechanism of cancer, and provide new insights into cancer diagnostics, prognostics and therapy.

[1]  A. Wellmann,et al.  Downregulation of Clusterin Expression in Testicular Germ Cell Tumours , 2001, Pathobiology.

[2]  D. Botstein,et al.  Gene expression patterns in human liver cancers. , 2002, Molecular biology of the cell.

[3]  M. Omary,et al.  Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. , 2006, Gastroenterology.

[4]  A. Chambers,et al.  Role of osteopontin in tumour progression , 2004, British Journal of Cancer.

[5]  Tak-Hong Cheung,et al.  Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  Xiao-Ming Yin.  Bid, a BH3-only multi-functional molecule, is at the cross road of life and death. , 2006, Gene.

[7]  L. French,et al.  Myc-transformed epithelial cells down-regulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo. , 2004, Cancer research.

[8]  Shridar Ganesan,et al.  X chromosomal abnormalities in basal-like human breast cancer. , 2006, Cancer cell.

[9]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[10]  W. Kaelin,et al.  Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein. , 2006, The American journal of pathology.

[11]  Xiaohang Zhao,et al.  Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches. , 2003, World journal of gastroenterology.

[12]  M. van de Rijn,et al.  Gene expression profiles of cutaneous B cell lymphoma. , 2003, The Journal of investigative dermatology.

[13]  G. Reifenberger,et al.  Expression of Bcl-2 family member Bid in normal and malignant tissues. , 2002, Neoplasia.

[14]  K. Yarasheski,et al.  Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapy. , 2005, Metabolism: clinical and experimental.

[15]  D. Lockhart,et al.  Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Donald Geman,et al.  Large-scale integration of cancer microarray data identifies a robust common cancer signature , 2007, BMC Bioinformatics.

[17]  P. Brown,et al.  Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. Ørntoft,et al.  Clusterin Expression in Normal Mucosa and Colorectal Cancer*S , 2007, Molecular & Cellular Proteomics.

[19]  T. Poggio,et al.  Multiclass cancer diagnosis using tumor gene expression signatures , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  L. Recht,et al.  Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Olivier Poch,et al.  Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis , 2004, Oncogene.

[22]  M. Scaltriti,et al.  Clusterin (SGP‐2, ApoJ) expression is downregulated in low‐ and high‐grade human prostate cancer , 2004, International journal of cancer.

[23]  F. Marshall.  Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data. , 2005, The Journal of urology.

[24]  R. Tibshirani,et al.  Gene expression profiling identifies clinically relevant subtypes of prostate cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Ellerby,et al.  Lysosomal Protease Pathways to Apoptosis , 2001, The Journal of Biological Chemistry.

[26]  David J Sugarbaker,et al.  Tumorigenesis and Neoplastic Progression Identification of Novel Candidate Oncogenes and Tumor Suppressors in Malignant Pleural Mesothelioma Using Large-Scale Transcriptional Profiling , 2005 .

[27]  Shinichiro Wachi,et al.  Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues , 2005, Bioinform..

[28]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[29]  R. Puri,et al.  Gene expression in human embryonic stem cell lines: unique molecular signature. , 2004, Blood.

[30]  David E. Misek,et al.  Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. , 2001, Cancer research.

[31]  Raphael A Nemenoff,et al.  Tumorigenesis and Neoplastic Progression Analysis of Orthologous Gene Expression between Human Pulmonary Adenocarcinoma and a Carcinogen-Induced Murine Model , 2010 .

[32]  J. D. Vos,et al.  Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays , 2002, Oncogene.

[33]  Yixin Wang,et al.  Gene-expression signatures in oncology diagnostics. , 2006, Pharmacogenomics.

[34]  R. Lothe,et al.  Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. , 2005, Cancer research.

[35]  C Eng,et al.  Gene expression in papillary thyroid carcinoma reveals highly consistent profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  D. Denhardt,et al.  Osteopontin is required for full expression of the transformed phenotype by the ras oncogene , 2000, British Journal of Cancer.

[37]  A. Olshen,et al.  Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. , 2006, Cancer research.

[38]  A. Berchuck,et al.  Microarray Analysis of Endometrial Carcinomas and Mixed Mullerian Tumors Reveals Distinct Gene Expression Profiles Associated with Different Histologic Types of Uterine Cancer , 2005, Clinical Cancer Research.

[39]  E. Lander,et al.  Gene expression correlates of clinical prostate cancer behavior. , 2002, Cancer cell.

[40]  J. Gregg,et al.  Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis. , 2004, Fertility and sterility.

[41]  Christine A Iacobuzio-Donahue,et al.  Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. , 2003, The American journal of pathology.

[42]  P. Brown,et al.  Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Otto Warburn,et al.  THE METABOLISM OF TUMORS , 1931 .

[44]  P. Gaffney,et al.  Identification of a Gene Expression Signature Associated with Recurrent Disease in Squamous Cell Carcinoma of the Head and Neck , 2004, Cancer Research.

[45]  E. Lander,et al.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D. Botstein,et al.  Variation in gene expression patterns in human gastric cancers. , 2003, Molecular biology of the cell.

[47]  Amir Jazaeri,et al.  Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer. , 2003, Cancer research.

[48]  Masha Kocherginsky,et al.  Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. , 2005, Cancer research.

[49]  John T. Wei,et al.  Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. , 2005, Cancer cell.

[50]  P. Park,et al.  Angiogenic profile of soft tissue sarcomas based on analysis of circulating factors and microarray gene expression. , 2006, The Journal of surgical research.

[51]  L. Recht,et al.  Tumor Necrosis Factor-α–Induced Protein 3 As a Putative Regulator of Nuclear Factor-κB–Mediated Resistance to O6-Alkylating Agents in Human Glioblastomas , 2006 .

[52]  Yixin Wang,et al.  Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions , 2005, Clinical Cancer Research.

[53]  Charles Auffray,et al.  Deciphering cellular states of innate tumor drug responses , 2006, Genome Biology.

[54]  Daohai Zhang,et al.  Proteomic Study Reveals That Proteins Involved in Metabolic and Detoxification Pathways Are Highly Expressed in HER-2/neu-positive Breast Cancer* , 2005, Molecular & Cellular Proteomics.

[55]  U. Alon,et al.  Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Shuichi Tsutsumi,et al.  Global gene expression analysis of gastric cancer by oligonucleotide microarrays. , 2002, Cancer research.

[57]  S. Su,et al.  Expression of Clusterin in Human Pancreatic Cancer , 2002, Pancreas.

[58]  John Crowley,et al.  Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. , 2002, Blood.

[59]  Mogens Kruhøffer,et al.  Gene Expression in the Urinary Bladder , 2004, Cancer Research.